...
首页> 外文期刊>Brain pathology >Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of A beta
【24h】

Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of A beta

机译:在阿尔茨海默病的疾病中,聚合物水平增加,影响了β的区域分布

获取原文
获取原文并翻译 | 示例

摘要

Clusterin, also known as apoJ, is a lipoprotein abundantly expressed within the CNS. It regulates A fibril formation and toxicity and facilitates amyloid-beta (A) transport across the blood-brain barrier. Genome-wide association studies have shown variations in the clusterin gene (CLU) to influence the risk of developing sporadic Alzheimer's disease (AD). To explore whether clusterin modulates the regional deposition of A, we measured levels of soluble (NP40-extracted) and insoluble (guanidine-HCl-extracted) clusterin, A beta 40 and A beta 42 by sandwich ELISA in brain regions with a predilection for amyloid pathologymid-frontal cortex (MF), cingulate cortex (CC), parahippocampal cortex (PH), and regions with little or no pathologythalamus (TH) and white matter (WM). Clusterin level was highest in regions with plaque pathology (MF, CC, PH and PC), approximately mirroring the regional distribution of A. It was significantly higher in AD than controls, and correlated positively with A beta 42 and insoluble A beta 40. Soluble clusterin level rose significantly with severity of cerebral amyloid angiopathy, and in MF and PC regions was highest in APOE 4 homozygotes. In the TH and WM (areas with little amyloid pathology) clusterin was unaltered in AD and did not correlate with A level. There was a significant positive correlation between the concentration of clusterin and the regional levels of insoluble A beta 42; however, the molar ratio of clusterin : A beta 42 declined with insoluble A beta 42 level in a region-dependent manner, being lowest in regions with predilection for A plaque pathology. Under physiological conditions, clusterin reduces aggregation and promotes clearance of A. Our findings indicate that in AD, clusterin increases, particularly in regions with most abundant A beta, but because the increase does not match the rising level of A beta 42, the molar ratio of clusterin : A beta 42 in those regions falls, probably contributing to A deposition within the tissue.
机译:Clusterin,也称为APOJ,是在CNS内大量表达的脂蛋白。它调节纤维形成和毒性,并促进淀粉样蛋白β(a)血型脑屏障的运输。基因组 - 范围的协会研究表明了群体基因(CLU)的变化,以影响发育孢子族阿尔茨海默病(AD)的风险。为了探索簇蛋白是否调节A的区域沉积,我们测量可溶性(NP40提取的)和不溶性(胍 - HCl提取的)簇蛋白,β40和β22的水平,在脑区域中夹心ELISA在具有淀粉样蛋白的倾向的脑区中病理阶段 - 正面皮质(MF),Cingulate Cortex(CC),PARAHIPPocampal皮质(pH)和具有很少或没有病理物(TH)和白质(WM)的地区。斑点水平在具有斑块病理学(MF,CC,pH和PC)的区域中最高,近似镜像A的区域分布。AD中的ad比对照显着高,并用β22和不溶性β40呈正相关。可溶Clusterin水平显着升高了脑淀粉样血管病变的严重程度,并且在MF和PC区中的ApoE 4纯合子中最高。在Th和WM(具有少量淀粉样蛋白病理学的区域)在AD中未替换蛋白质,并没有与水平相关。簇素浓度与不溶性β22的区域水平之间存在显着的正相关;然而,簇蛋白的摩尔比:β22以区域依赖性方式不溶于不溶性β22水平,在具有斑块病理学的偏移的区域中最低。在生理条件下,Clusterin降低了聚集并促进了A的清除。我们的研究结果表明,在AD中,Clusterin增加,特别是在具有丰富β的地区,但由于增加与β22的上升水平,摩尔比率不匹配。群体:这些区域中的β22落下,可能导致组织内的沉积。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号